FIELD: medicine.
SUBSTANCE: application of 3% catolyte of a sodium chloride solution with ORP parametres minus 450-600 mV, pH - 8.2-9.5 for treatment of depressions is offered. It is shown in experiments and in clinical practice that 3% catolyte of a sodium chloride solution with ORP parametres minus 450-600 mV, pH - 8.2-9.5 possesses potentiating activity in relation to antidepressive preparations, besides, has own antidepressive effect.
EFFECT: development of an agent which possesses potentiating activity in relation to antidepressive preparations, besides, has own antidepressive effect.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTANCE ELICITING ANTIDEPRESSANT ACTIVITY | 2003 |
|
RU2232578C1 |
| ANTIDEPRESSANT FOR CORRECTION OF SIDE EFFECTS FROM NEUROLEPTICS | 2019 |
|
RU2746012C2 |
| 1-(1,1-DIOXOTIETHAN-3-yl)-4-(2-OXO-2-PHENYLETHIL)-1,2,4-TRIAZOL-4-th BROMIDE, SHOWING ANTIDEPRESSIVE ACTIVITY | 2022 |
|
RU2785340C1 |
| METHOD OF CORRECTING DEPRESSIVE DISORDERS BY THIETAN-1,1-DIOXIDE DERIVATIVES IN EXPERIMENT | 2010 |
|
RU2424799C1 |
| 9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
| ANTIDEPRESSANT | 2012 |
|
RU2535027C2 |
| N-MONO- AND N,N-DITHIETANE-CONTAINING 5-BROMO-2,4-DIHYDRO-1,2,4-TRIAZOL-3-ONES, EXHIBITING ANTIDEPRESSANT ACTIVITY | 2024 |
|
RU2826999C1 |
| AGENT POSSESSING ANTIDEPRESSANT ACTIVITY | 2015 |
|
RU2601914C1 |
| ANTIDEPRESSANT DRUG AND METHOD FOR PREPARING IT | 2013 |
|
RU2519759C1 |
| 5-BROMO-2-(THIETAN-3-YL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE DERIVATIVES, EXHIBITING ANTIDEPRESSANT ACTIVITY | 2011 |
|
RU2459818C1 |
